Rituximab, ofatumumab and other monoclonal anti‐CD20 antibodies for chronic lymphocytic leukaemia

Overview of attention for article published in Cochrane database of systematic reviews, November 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 58 Dimensions

Readers on

mendeley: 194 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 7,702 followers.

@mcbio316 thanks for the slide. This is useful $TGTX. I am going through the slides. read this http://t.co/BLa0x0ragu. it is a good article

14 Apr 2013

Reply Repost Favourite

Rituximab, ofatumumab y otros monoclonales anti-CD20 para la leucemia linfocítica crónica| Cochrane Database Syst Rev http://t.co/YywrlxiU

24 Nov 2012

Reply Repost Favourite

RT @Oncologia_com: Rituximab, ofatumumab y otros monoclonales anti-CD20 para la leucemia linfocítica crónica| Cochrane Database Syst Rev http://t.co/YywrlxiU

21 Nov 2012

Reply Repost Favourite

Rituximab, ofatumumab y otros monoclonales anti-CD20 para la leucemia linfocítica crónica| Cochrane Database Syst Rev http://t.co/YywrlxiU

17 Nov 2012

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.